Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523711 | SCV000618225 | likely benign | not provided | 2021-08-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26820064) |
Invitae | RCV001078778 | SCV000659438 | likely benign | Adams-Oliver syndrome 5 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000770630 | SCV000739413 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-07-06 | criteria provided, single submitter | clinical testing | The p.T1344M variant (also known as c.4031C>T), located in coding exon 25 of the NOTCH1 gene, results from a C to T substitution at nucleotide position 4031. The threonine at codon 1344 is replaced by methionine, an amino acid with similar properties. This alteration was described in patients with left-sided congenital heart disease (Kerstjens-Frederikse WS et al. Genet. Med., 2016 09;18:914-23). This alteration was also identified in 1/1358 non-cancer control individuals and in 0/57 cases, in a study looking at cancer predisposition mutations in patients with cutaneous melanoma and a history of at least two additional non-cutaneous melanoma primary cancers (Pritchard AL et al. PLoS One, 2018 Apr;13:e0194098).This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770630 | SCV000902081 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-11-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987578 | SCV004803473 | likely benign | not specified | 2024-01-16 | criteria provided, single submitter | clinical testing | Variant summary: NOTCH1 c.4031C>T (p.Thr1344Met) results in a non-conservative amino acid change located in the EGF-like domain (IPR000742) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00045 in 215554 control chromosomes. The observed variant frequency is approximately 14-fold of the estimated maximal expected allele frequency for a pathogenic variant in NOTCH1 causing Aortic Valve Disease phenotype (3.1e-05), strongly suggesting that the variant is benign. c.4031C>T has been reported in the literature as a VUS in individuals affected with left-sided congenital heart disease (Kerstjens-Frederikse_2016) and thoracic aortic aneurysm (Salmasi_2022), without strong evidence for causality. These reports do not provide unequivocal conclusions about association of the variant with Aortic Valve Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26820064, 35830949). ClinVar contains an entry for this variant (Variation ID: 449810). Based on the evidence outlined above, the variant was classified as likely benign. |
Laboratory of Diagnostic Genome Analysis, |
RCV000523711 | SCV001797871 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000523711 | SCV001966219 | uncertain significance | not provided | no assertion criteria provided | clinical testing |